Patient Registry Software Market Size to Reach USD 2.96 Billion in 2027 Growing at a CAGR of 13.9%, according to Emergen Research
Emergen Research has published its latest report titled “Patient Registry Software Market By Delivery, By Database, By Registry Type, By Function, By Software Type (Integrated, Standalone), By End-use (Government & Third-Party Administrators, Pharmaceutical Companies, Hospitals, Research Centers, Others), and By Region, Forecast to 2027”
According to Emergen Research, the global patient registry software market size was USD 1.10 Billion in 2019 and is expected to reach USD 2.96 Billion in 2027 and register a revenue CAGR of 13.9% during the forecast period, 2020-2027.
A patient registry is a system that stores detailed information on patients as well as their medical histories to evaluate predefined outcomes for a population defined by a specific disease that helps in clinical, and scientific experiments. Patient Registry Software can collect information and create a database indefinite number of patients. Pharmaceutical corporations, medical research organizations, and hospitals use this software to quickly collect data on groups of patients participating in clinical trials, which surge demand for patient registry software in the market. The number of registries has increased throughout the years as healthcare data has become more computerized.
In addition, patient registries are being developed by a rising number of pharmaceutical companies and patient foundations to investigate the treatment of uncommon diseases and disorders including hereditary diseases which drives market revenue growth in the market. The software can also be used to conduct a single, targeted research agenda, gathering data to answer a specific research question. For the past decade, patient registry data have increasingly been applied for post-marketing observation and real-world evidence. However, growing concern regarding data leak, security and rising number of cyber-attacks coupled with high investments required in maintenance of patent registries are some factors expected to restrain global patient registry software market over the forecast period.
Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/465
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Disease Registries Segment Revenue to Expand at a Rapid CAGR:
Disease registries segment is expected to register rapid revenue CAGR during the forecast period owing to increasing need to understand treatments and outcomes of various diseases. A disease registry is a mechanism for keeping track of a patient population's clinical care and outcomes. The majority of disease registries are used to help manage the care of groups of people who have one or more chronic conditions, such as coronary artery disease, diabetes, or asthma.
Government & Third-Party Administrators Segment to Register Significant Revenue Growth:
Government & third-party administrators segment is expected to dominate other segments in terms of revenue growth over the forecast period due to rising focus on minimizing healthcare burden, growing use of patient registry software to treat patients suffering from chronic diseases in government organizations, and increasing initiatives towards providing value-based care.
North America to Account for Largest Revenue Share:
North America is expected to account for largest revenue share in the global market over the forecast period due to growing elderly population, increasing number of patients suffering from chronic diseases and rising focus on offering value based care to patients. In addition, development and implementation of point-of-care management, and implementation of digital infrastructure in hospitals and clinics are some other factors expected to fuel market revenue growth of the region throughout the forecast period.
Buy your Exclusive copy@ https://www.emergenresearch.com/select-license/465
Major Companies in the Market Include:
- IQVIA Holdings, Inc.
- ImageTrend, Inc.
- McKesson Corporation
- Optum, Inc.
- International Business Machines Corporation
- Syneos Health Inc.
- Premier, Inc.
- Phytel, Inc.
- Telligen, Inc.
- Dacima Software Inc.
For the purpose of this report, Emergen Research has segmented the global patient registry software market on the basis of delivery, database, registry type, function, software type, end-use, and region.
Delivery Outlook (Revenue, USD Billion; 2020–2027)
Database Outlook (Revenue, USD Billion; 2020–2027)
- Public Database
- Commercial Database
Registry Type Outlook (Revenue, USD Billion; 2020–2027)
- Product Registries
- Health Service Registries
- Disease Registries
Function Outlook (Revenue, USD Billion; 2020–2027)
- Patient Care Management
- Population Health Management
- Product Outcome Evaluation
- Health Information Exchange
- Research & Clinical Studies
Software Type Outlook (Revenue, USD Billion; 2020–2027)
End-use Outlook (Revenue, USD Billion; 2020–2027)
- Government & Third-Party Administrators
- Pharmaceutical Companies
- Research Centers
Regional Outlook (Revenue, USD Billion; 2020–2027)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
Cannabis Market By Product Type (Flower, Concentrates, Others), By Compound (Tetrahydrocannabinol, Cannabidiol (CBD), Balanced THC & CBD), By Application (Medical, Recreational, Pain Management, Neurological Health Management, Others), and Regions Forecasts to 2027
Drug Infusion Systems Market By Control Systems (Open Loop System, Closed Loop System), By Infusion Type (Continuous Infusion, Intermittent Infusion, Patient Controlled Infusion, Total Parenteral Nutrition), By Administration Route, By Application, By End-Use, and By Region Forecast to 2028
Compound Management Market By Solution (Products and Outsourcing Services), By Sample Type (Chemical Compounds, Biosamples), By Application (Drug Discovery, Gene Synthesis, Biobanking, Others), By End-Use (Biopharma Companies, Pharma Companies, Biobank, CRO) and By Region Forecast to 2028
Nanotechnology Market Size, Share, Trends, By Type (Nanomaterials, Nanocomposites, Nano devices, Nano tools), By Industry (Food and Agriculture, Healthcare, Information and Technology, Environment, Energy, Cosmetics), and By Region, Forecast to 2028
In-vitro Fertilization: Overcoming Insurmountable Barriers of Infertility
Joint Reconstruction Devices: Addressing the Need for Long-term Relief from Orthopedic Diseases
Liquid Biopsy: A Revolution in the Field of Medical Oncology
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756